Lista de obras -

A DEAD box protein facilitates HIV-1 replication as a cellular co-factor of Rev.

artículo científico publicado en 2004

A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent Clostridium difficile Infection

artículo científico publicado en 2016

A Phase 1b safety study of SER-287, a spore-based microbiome therapeutic, for active mild to moderate ulcerative colitis

scientific article published on 04 August 2020

A trans-dominant negative HIV type 1 Rev with intact domains of NLS/NOS and NES

scientific article published on 01 July 2002

AIDS 2002. Virology: overview

artículo científico publicado el 1 de enero de 2002

ATM: HIV-1's Achilles heel?

artículo científico publicado en 2005

Anti-HIV-1 microbicides -- 'chemical condoms' designed to limit the scourge of the HIV-1 pandemic.

artículo científico publicado en 2005

Antiretroviral therapy in the developing world

artículo científico publicado en 2005

Antiviral effects of human immunodeficiency virus type 1-specific small interfering RNAs against targets conserved in select neurotropic viral strains

artículo científico publicado en 2004

Antiviral potentials of medicinal plants

artículo científico publicado en 2007

Approaching eradication of highly active antiretroviral therapy-persistent human immunodeficiency virus type 1 reservoirs with immune activation therapy.

artículo científico publicado en 2002

Attenuation of HIV-1 infection by other microbial agents

artículo científico publicado en 2005

Binding of ALX40-4C to APJ, a CNS-based receptor, inhibits its utilization as a co-receptor by HIV-1.

artículo científico publicado en 2003

Binding of Intracellular Anti-Rev Single Chain Variable Fragments to Different Epitopes of Human Immunodeficiency Virus Type 1 Rev: Variations in Viral Inhibition

Caffeine inhibits human immunodeficiency virus type 1 transduction of nondividing cells

artículo científico publicado en 2005

Cell-cell fusion and internalization of the CNS-based, HIV-1 co-receptor, APJ

artículo científico publicado en 2003

Cell-type-specific gene delivery into neuronal cells in vitro and in vivo

artículo científico publicado en 2003

Central nervous system infections in individuals with HIV-1 infection

artículo científico publicado en 2002

Cholesterol-depleting statin drugs protect postmitotically differentiated human neurons against ethanol- and human immunodeficiency virus type 1-induced oxidative stress in vitro

artículo científico publicado en 2006

Combination Genetic Therapy to Inhibit HIV-1 ⬇️

artículo científico publicado el 1 de enero de 2002

Combined effects of hyperglycemic conditions and HIV-1 Nef: a potential model for induced HIV neuropathogenesis

artículo científico publicado en 2009

Covalently linked human immunodeficiency virus type 1 gp120/gp41 is stably anchored in rhabdovirus particles and exposes critical neutralizing epitopes

artículo científico publicado en 2003

Cross-packaging of human immunodeficiency virus type 1 vector RNA by spleen necrosis virus proteins: construction of a new generation of spleen necrosis virus-derived retroviral vectors

artículo científico publicado en 2004

Cross-talk and viral reservoirs

artículo científico publicado en 2003

Current status of gene therapy strategies to treat HIV/AIDS.

artículo científico publicado en 2005

Daily Low-Dose Subcutaneous Interleukin-2 Added To Single- or Dual-Nucleoside Therapy in HIV Infection Does Not Protect Against CD4+ T-Cell Decline or Improve Other Indices of Immune Function: Results of a Randomized Controlled Clinical Trial (ACTG 2

article

Down-modulation of the CXCR4 co-receptor by intracellular expression of a single chain variable fragment (SFv) inhibits HIV-1 entry into primary human brain microvascular endothelial cells and post-mitotic neurons

artículo científico publicado en 2005

Effects of HIV-1 Vpr on neuroinvasion and neuropathogenesis

artículo científico publicado en 2004

Effects of highly active antiretroviral therapy on HIV-1-associated oral complications

artículo científico publicado en 2007

Eliminating HIV-1 reservoirs

artículo científico publicado en 2002

Ethanol potentiates HIV-1 gp120-induced apoptosis in human neurons via both the death receptor and NMDA receptor pathways

artículo científico publicado en 2005

Ethanol strongly potentiates apoptosis induced by HIV-1 proteins in primary human brain microvascular endothelial cells

artículo científico publicado en 2002

Exebacase for Staphylococcus aureus bloodstream infection and endocarditis

scientific article published on 09 April 2020

Exogenous IL-7 induces Fas-mediated human neuronal apoptosis: potential effects during human immunodeficiency virus type 1 infection.

artículo científico publicado en 2005

Expression of latent HAART-persistent HIV type 1 induced by novel cellular activating agents

artículo científico publicado en 2004

First International Workshop on HIV-1 Persistence During Therapy

artículo científico publicado en 2004

Gene therapy using a simian virus 40-derived vector inhibits the development of in vivo human immunodeficiency virus type 1 infection of severe combined immunodeficiency mice implanted with human fetal thymic and liver tissue.

artículo científico publicado en 2002

Generation of retroviral particles for the spleen necrosis virus (SNV)-based vector system and their use in transduction of various cell types

artículo científico publicado en 2010

Genotypic alteration of HAART-persistent HIV-1 reservoirs in vivo ⬇️

artículo científico publicado el 30 de septiembre de 2003

HIV and GB virus C--can two viruses be better than one?

artículo científico publicado en 2004

HIV type 1 cervicovaginal reservoirs in the era of HAART

artículo científico publicado en 2005

HIV-1 Vif versus APOBEC3G: newly appreciated warriors in the ancient battle between virus and host

artículo científico publicado en 2004

HIV-1 Vpr potently induces programmed cell death in the CNS in vivo

artículo científico publicado en 2007

HIV-1 infection and genomics: sorting out the complexity

artículo científico publicado en 2004

HIV-1 reservoirs

artículo científico publicado en 2002

HIV-1-mediated apoptosis of neuronal cells: Proximal molecular mechanisms of HIV-1-induced encephalopathy

artículo científico publicado en 2004

HIV: a tough viral nut to crack

artículo científico publicado en 2002

Hide-and-seek: the challenge of viral persistence in HIV-1 infection

artículo científico publicado en 2008

Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6P Env and simian immunodeficiency virusmac239 Gag are safe in rhesus macaques and protect from an AIDS-like disease

artículo científico publicado en 2007

Human Immunodeficiency virus type 1 Nef potently induces apoptosis in primary human brain microvascular endothelial cells via the activation of caspases

artículo científico publicado en 2005

Human immunodeficiency virus type 1 enters primary human brain microvascular endothelial cells by a mechanism involving cell surface proteoglycans independent of lipid rafts

artículo científico publicado en 2003

IL-7 as a potential therapy for HIV-1-infected individuals

artículo científico publicado en 2005

IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART.

artículo científico publicado en 2005

Immune reconstitution syndrome in AIDS. Interview by Vicki Glaser

artículo científico publicado en 2003

Immunogenicity study of glycoprotein-deficient rabies virus expressing simian/human immunodeficiency virus SHIV89.6P envelope in a rhesus macaque

artículo científico publicado en 2004

In a subset of subjects on highly active antiretroviral therapy, human immunodeficiency virus type 1 RNA in plasma decays from 50 to <5 copies per milliliter, with a half-life of 6 months

artículo científico publicado en 2003

Inhibition of HIV-1 in the central nervous system by IFN-alpha2 delivered by an SV40 vector.

artículo científico publicado en 2003

Inhibition of HIV-1 replication by caffeine and caffeine-related methylxanthines

artículo científico publicado en 2005

Inhibition of endogenous reverse transcription of human and nonhuman primate lentiviruses: potential for development of lentivirucides

artículo científico publicado en 2006

Intensification and stimulation therapy for human immunodeficiency virus type 1 reservoirs in infected persons receiving virally suppressive highly active antiretroviral therapy

artículo científico publicado en 2002

Intracellular Expression of Single-Chain Variable Fragments To Inhibit Early Stages of the Viral Life Cycle by Targeting Human Immunodeficiency Virus Type 1 Integrase

Kynurenine pathway metabolism in human blood-brain-barrier cells: implications for immune tolerance and neurotoxicity.

artículo científico publicado en 2008

Lentiviral expression of HIV-1 Vpr induces apoptosis in human neurons

artículo científico publicado en 2002

Live and killed rhabdovirus-based vectors as potential hepatitis C vaccines

artículo científico publicado en 2002

Ludwik Hirszfeld Memorial Lecture: HIV-1 reservoirs: major molecular obstacles to viral eradication.

artículo científico publicado en 2004

Molecular interactions of human immunodeficiency virus type 1 with primary human oral keratinocytes.

artículo científico publicado en 2005

Mutation of the Rev-binding loop in the human immunodeficiency virus 1 leader causes a replication defect characterized by altered RNA trafficking and packaging

artículo científico publicado en 2006

New methods for the detection of HIV.

artículo científico publicado en 2002

Pentoxifylline suppresses transduction by HIV-1-based vectors.

artículo científico publicado en 2007

Peripheral blood Dendritic cells are not a major reservoir for HIV type 1 in infected individuals on virally suppressive HAART.

artículo científico publicado en 2003

Potent Inhibition of Human Immunodeficiency Virus Type 1 in Primary T Cells and Alveolar Macrophages by a Combination Anti-Rev Strategy Delivered in an Adeno-Associated Virus Vector

Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins

artículo científico publicado en 2002

Primary isolated human brain microvascular endothelial cells express diverse HIV/SIV-associated chemokine coreceptors and DC-SIGN and L-SIGN.

artículo científico publicado en 2002

RNA interference meets HIV-1: will silence be golden?

scientific article published on 01 July 2002

RNA interference: on the road to an alternate therapeutic strategy!

artículo científico publicado en 2003

RNA interference:a potential novel therapeutic combating HIV-1 in the central nervous system.

artículo científico publicado en 2004

Rabies virus glycoprotein as a carrier for anthrax protective antigen

artículo científico publicado en 2006

Recombinant rhabdoviruses as potential vaccines for HIV-1 and other diseases

artículo científico publicado en 2003

Replication of lentiviruses

artículo científico publicado en 2003

Reply to Lagier et al

scientific article published on 20 October 2016

Reservoirs of Human Immunodeficiency Virus Type 1: The Main Obstacles to Viral Eradication ⬇️

artículo científico publicado el 21 de noviembre de 2001

Reservoirs, sanctuaries, and residual disease: the hiding spots of HIV-1.

artículo científico publicado en 2003

Residual HIV-1 disease in seminal cells of HIV-1-infected men on suppressive HAART: latency without on-going cellular infections ⬇️

artículo científico publicado el 4 de enero de 2002

Rev binds specifically to a purine loop in the SL1 region of the HIV-1 leader RNA

artículo científico publicado en 2003

Rhabdovirus-based vectors with human immunodeficiency virus type 1 (HIV-1) envelopes display HIV-1-like tropism and target human dendritic cells

artículo científico publicado en 2002

SER-109, an Investigational Microbiome Drug to Reduce Recurrence after Clostridioides difficile infection: Lessons Learned from a Phase 2 Trial

scientific article published on 07 April 2020

Safety, tolerability, and pharmacokinetic effects of thalidomide in patients infected with human immunodeficiency virus: AIDS Clinical Trials Group 267.

artículo científico publicado en 2002

Second-generation rabies virus-based vaccine vectors expressing human immunodeficiency virus type 1 gag have greatly reduced pathogenicity but are highly immunogenic

artículo científico publicado en 2003

Seminal reservoirs during an HIV type 1 eradication trial

artículo científico publicado en 2005

Slower progression of HIV-1 infection in persons with GB virus C co-infection correlates with an intact T-helper 1 cytokine profile

artículo científico publicado en 2003

Spleen necrosis virus-based vector delivery of anti-HIV-1 genes potently protects human hematopoietic cells from HIV-1 infection

artículo científico publicado en 2005

Spliced spleen necrosis virus vector RNA is not encapsidated: implications for retroviral replication and vector design

artículo científico publicado en 2004

Structural and functional study of the apelin-13 peptide, an endogenous ligand of the HIV-1 coreceptor, APJ.

artículo científico publicado en 2003

T-Cells and excitotoxicity: HIV-1 and other neurodegenerative disorders

artículo científico publicado en 2005

The N-terminal domain of APJ, a CNS-based coreceptor for HIV-1, is essential for its receptor function and coreceptor activity

artículo científico publicado en 2003

The RNA helicase DDX1 is involved in restricted HIV-1 Rev function in human astrocytes

artículo científico publicado en 2005

The challenge of finding a cure for HIV infection

artículo científico publicado en 2009

The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA

artículo científico publicado en 2003

The perlecan heparan sulfate proteoglycan mediates cellular uptake of HIV-1 Tat through a pathway responsible for biological activity

artículo científico publicado en 2004

Treatment of Mycobacterium avium complex immune reconstitution disease in HIV-1-infected individuals

artículo científico publicado en 2003

Twenty years of therapy for HIV-1 infection

artículo científico publicado en 2003

Unsung Hero Robert C. Gallo

artículo científico publicado en 2009

siRNA targeting vaccinia virus double-stranded RNA binding protein [E3L] exerts potent antiviral effects

artículo científico publicado en 2006

Lista de obras de

A DEAD box protein facilitates HIV-1 replication as a cellular co-factor of Rev.

A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent Clostridium difficile Infection

A Phase 1b safety study of SER-287, a spore-based microbiome therapeutic, for active mild to moderate ulcerative colitis

A trans-dominant negative HIV type 1 Rev with intact domains of NLS/NOS and NES

AIDS 2002. Virology: overview

ATM: HIV-1's Achilles heel?

Anti-HIV-1 microbicides -- 'chemical condoms' designed to limit the scourge of the HIV-1 pandemic.

Antiretroviral therapy in the developing world

Antiviral effects of human immunodeficiency virus type 1-specific small interfering RNAs against targets conserved in select neurotropic viral strains

Antiviral potentials of medicinal plants

Approaching eradication of highly active antiretroviral therapy-persistent human immunodeficiency virus type 1 reservoirs with immune activation therapy.

Attenuation of HIV-1 infection by other microbial agents

Binding of ALX40-4C to APJ, a CNS-based receptor, inhibits its utilization as a co-receptor by HIV-1.

Binding of Intracellular Anti-Rev Single Chain Variable Fragments to Different Epitopes of Human Immunodeficiency Virus Type 1 Rev: Variations in Viral Inhibition

Caffeine inhibits human immunodeficiency virus type 1 transduction of nondividing cells

Cell-cell fusion and internalization of the CNS-based, HIV-1 co-receptor, APJ

Cell-type-specific gene delivery into neuronal cells in vitro and in vivo

Central nervous system infections in individuals with HIV-1 infection

Cholesterol-depleting statin drugs protect postmitotically differentiated human neurons against ethanol- and human immunodeficiency virus type 1-induced oxidative stress in vitro

Combination Genetic Therapy to Inhibit HIV-1 ⬇️

Combined effects of hyperglycemic conditions and HIV-1 Nef: a potential model for induced HIV neuropathogenesis

Covalently linked human immunodeficiency virus type 1 gp120/gp41 is stably anchored in rhabdovirus particles and exposes critical neutralizing epitopes

Cross-packaging of human immunodeficiency virus type 1 vector RNA by spleen necrosis virus proteins: construction of a new generation of spleen necrosis virus-derived retroviral vectors

Cross-talk and viral reservoirs

Current status of gene therapy strategies to treat HIV/AIDS.

Daily Low-Dose Subcutaneous Interleukin-2 Added To Single- or Dual-Nucleoside Therapy in HIV Infection Does Not Protect Against CD4+ T-Cell Decline or Improve Other Indices of Immune Function: Results of a Randomized Controlled Clinical Trial (ACTG 2

Down-modulation of the CXCR4 co-receptor by intracellular expression of a single chain variable fragment (SFv) inhibits HIV-1 entry into primary human brain microvascular endothelial cells and post-mitotic neurons

Effects of HIV-1 Vpr on neuroinvasion and neuropathogenesis

Effects of highly active antiretroviral therapy on HIV-1-associated oral complications

Eliminating HIV-1 reservoirs

Ethanol potentiates HIV-1 gp120-induced apoptosis in human neurons via both the death receptor and NMDA receptor pathways

Ethanol strongly potentiates apoptosis induced by HIV-1 proteins in primary human brain microvascular endothelial cells

Exebacase for Staphylococcus aureus bloodstream infection and endocarditis

Exogenous IL-7 induces Fas-mediated human neuronal apoptosis: potential effects during human immunodeficiency virus type 1 infection.

Expression of latent HAART-persistent HIV type 1 induced by novel cellular activating agents

First International Workshop on HIV-1 Persistence During Therapy

Gene therapy using a simian virus 40-derived vector inhibits the development of in vivo human immunodeficiency virus type 1 infection of severe combined immunodeficiency mice implanted with human fetal thymic and liver tissue.

Generation of retroviral particles for the spleen necrosis virus (SNV)-based vector system and their use in transduction of various cell types

Genotypic alteration of HAART-persistent HIV-1 reservoirs in vivo ⬇️

HIV and GB virus C--can two viruses be better than one?

HIV type 1 cervicovaginal reservoirs in the era of HAART

HIV-1 Vif versus APOBEC3G: newly appreciated warriors in the ancient battle between virus and host

HIV-1 Vpr potently induces programmed cell death in the CNS in vivo

HIV-1 infection and genomics: sorting out the complexity

HIV-1 reservoirs

HIV-1-mediated apoptosis of neuronal cells: Proximal molecular mechanisms of HIV-1-induced encephalopathy

HIV: a tough viral nut to crack

Hide-and-seek: the challenge of viral persistence in HIV-1 infection

Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6P Env and simian immunodeficiency virusmac239 Gag are safe in rhesus macaques and protect from an AIDS-like disease

Human Immunodeficiency virus type 1 Nef potently induces apoptosis in primary human brain microvascular endothelial cells via the activation of caspases

Human immunodeficiency virus type 1 enters primary human brain microvascular endothelial cells by a mechanism involving cell surface proteoglycans independent of lipid rafts

IL-7 as a potential therapy for HIV-1-infected individuals

IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART.

Immune reconstitution syndrome in AIDS. Interview by Vicki Glaser

Immunogenicity study of glycoprotein-deficient rabies virus expressing simian/human immunodeficiency virus SHIV89.6P envelope in a rhesus macaque

In a subset of subjects on highly active antiretroviral therapy, human immunodeficiency virus type 1 RNA in plasma decays from 50 to <5 copies per milliliter, with a half-life of 6 months

Inhibition of HIV-1 in the central nervous system by IFN-alpha2 delivered by an SV40 vector.

Inhibition of HIV-1 replication by caffeine and caffeine-related methylxanthines

Inhibition of endogenous reverse transcription of human and nonhuman primate lentiviruses: potential for development of lentivirucides

Intensification and stimulation therapy for human immunodeficiency virus type 1 reservoirs in infected persons receiving virally suppressive highly active antiretroviral therapy

Intracellular Expression of Single-Chain Variable Fragments To Inhibit Early Stages of the Viral Life Cycle by Targeting Human Immunodeficiency Virus Type 1 Integrase

Intracellular Expression of Single-Chain Variable Fragments To Inhibit Early Stages of the Viral Life Cycle by Targeting Human Immunodeficiency Virus Type 1 Integrase

Kynurenine pathway metabolism in human blood-brain-barrier cells: implications for immune tolerance and neurotoxicity.

Lentiviral expression of HIV-1 Vpr induces apoptosis in human neurons

Live and killed rhabdovirus-based vectors as potential hepatitis C vaccines

Ludwik Hirszfeld Memorial Lecture: HIV-1 reservoirs: major molecular obstacles to viral eradication.

Molecular interactions of human immunodeficiency virus type 1 with primary human oral keratinocytes.

Mutation of the Rev-binding loop in the human immunodeficiency virus 1 leader causes a replication defect characterized by altered RNA trafficking and packaging

New methods for the detection of HIV.

Pentoxifylline suppresses transduction by HIV-1-based vectors.

Peripheral blood Dendritic cells are not a major reservoir for HIV type 1 in infected individuals on virally suppressive HAART.

Potent Inhibition of Human Immunodeficiency Virus Type 1 in Primary T Cells and Alveolar Macrophages by a Combination Anti-Rev Strategy Delivered in an Adeno-Associated Virus Vector

Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins

Primary isolated human brain microvascular endothelial cells express diverse HIV/SIV-associated chemokine coreceptors and DC-SIGN and L-SIGN.

RNA interference meets HIV-1: will silence be golden?

RNA interference: on the road to an alternate therapeutic strategy!

RNA interference:a potential novel therapeutic combating HIV-1 in the central nervous system.

Rabies virus glycoprotein as a carrier for anthrax protective antigen

Recombinant rhabdoviruses as potential vaccines for HIV-1 and other diseases